Sunday, October 11, 2026 7:00 AM ET
1 day ago
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come1 day ago
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday3 days ago
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia4 days ago
Jim Cramer says Grail can run higher as FDA decision on Galleri nears4 days ago
Russian lab worker's suspected plague death leaves experts puzzled4 days ago
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk5 days ago
AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos5 days ago
Russian lab worker dies amid plague reports. Here's what we know5 days ago
Russia hospitalizes almost 200 people after death from plague: Reports5 days ago
BioMarin reports five-year Pompe disease data showing durable motor function8 days ago
Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s8 days ago
Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion8 days ago
De-risking rare disease drug development8 days ago
Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock21 hours ago
$942 million: Insurer points finger at AI as suspect hospital charges appear9 days ago
Grindr expands beyond dating with $250 million PurposeMed acquisition9 days ago
Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial10 days ago
Novo's Wegovy pill improves weight loss after people switch from injections10 days ago
White House moves to block $810 million in funding through pocket rescission14 days ago
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s15 days ago
NIH cuts delayed a cancer trial. Patients lost time they didn't have15 days ago
Why we like Starbucks' latest turnaround move — plus, two more wins for Eli Lilly21 hours ago
Novo's new strategy hinges on something it can't manufacture: investor trust17 days ago
Trump administration removes around 760,000 Obamacare enrollments17 days ago
Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage18 days ago
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo19 days ago
Why more companies are fighting over beauty, health and wellness spending19 days ago
Mitch McConnell returns to Senate after three-month health absence26 days ago
Athletes with autism take center court at the US Open26 days ago
Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' strategy26 days ago
Record U.S. cyclosporiasis outbreak is over, CDC says29 days ago